Literature DB >> 24577385

Policies to aid the adoption of personalized medicine.

Charity Nofziger1, Marisa Papaluca2, Andre Terzic3, Scott Waldman4, Markus Paulmichl1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24577385      PMCID： PMC4404494          DOI： 10.1038/nrd4257

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

Review 1.  Pharmacogenetics in the evaluation of new drugs: a multiregional regulatory perspective.

Authors:  Marc Maliepaard; Charity Nofziger; Marisa Papaluca; Issam Zineh; Yoshiaki Uyama; Krishna Prasad; Christian Grimstein; Michael Pacanowski; Falk Ehmann; Silvia Dossena; Markus Paulmichl
Journal:  Nat Rev Drug Discov       Date:  2013-02       Impact factor: 84.694
  1 in total
  3 in total

1.  Red cells in post-genomic era: impact of personalized medicine in the treatment of anemias.

Authors:  Achille Iolascon; Immacolata Andolfo; Roberta Russo
Journal:  Haematologica       Date:  2015-01       Impact factor: 9.941

Review 2.  Pharmacogenomic information in drug labels: European Medicines Agency perspective.

Authors:  F Ehmann; L Caneva; K Prasad; M Paulmichl; M Maliepaard; A Llerena; M Ingelman-Sundberg; M Papaluca-Amati
Journal:  Pharmacogenomics J       Date:  2015-02-24       Impact factor: 3.550

3.  Blood glutamine synthetase signaling in alcohol use disorder and racial disparity.

Authors:  Lailun Nahar; Sarah E Kaufman; Patrick G Davis; Stephanie L Saunders; Elizabeth A Disbrow; James C Patterson; Hyung W Nam
Journal:  Transl Psychiatry       Date:  2022-02-22       Impact factor: 7.989
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.